Trials / Completed
CompletedNCT05341648
Aerobic Exercise and Covid-19 Survivors With Post-Intensive Care Syndrome (Pics)
Effects of Aerobic Exercise Program in Covid-19 Survivors With Post-Intensive Care Syndrome (Pics)
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 60 (actual)
- Sponsor
- Riphah International University · Academic / Other
- Sex
- All
- Age
- 30 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
To investigate the effects of aerobic exercise program on physical activity, aerobic capacity, anxiety\& depression in Covid-19 survivors discharged from Intensive Care Unit. There is evidence in the literature that post-intensive case survivors who have been mechanically ventilated will likely experience short- and medium-term consequences in the form of Post Intensive Care Syndrome (PICS).
Detailed description
The notion that patients surviving intensive care and mechanical ventilation for several weeks can be discharged home without further medical attention is a dangerous illusion. Post-Intensive Care Syndrome and other severe conditions will require not only adequate screening but early rehabilitation and other interventions. So, this focused control trial will contribute particularly to determining the Effects of the Aerobic Exercise Program in Covid-19 Survivors with Post-Intensive Care Syndrome.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Aerobic Exercise Training | Warm-up: 5 minutes Aerobic Training Treadmill/cycle ergometer Frequency:3 days a week Intensity:40-70% of HR max(Start from 40% than increment to as per patient tolerance) Total Duration:6 weeks. Duration of each session:15-30 mins. Cool-down: 5 minutes |
| OTHER | Home Plan | * Positions to ease breathlessness * Controlled breathing/Deep breathing\*10 Reps\* TD,s * Progressive Muscle Relaxation Exercises. * ROM \& Flexibility Exercises. 3 days a week for 6 weeks. |
Timeline
- Start date
- 2022-04-30
- Primary completion
- 2022-11-01
- Completion
- 2022-11-01
- First posted
- 2022-04-22
- Last updated
- 2022-11-28
Locations
1 site across 1 country: Pakistan
Source: ClinicalTrials.gov record NCT05341648. Inclusion in this directory is not an endorsement.